EFS
Essex Financial Services’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,407
| Closed | -$282K | – | 511 |
|
|
2022
Q1 | $282K | Buy |
3,407
+107
| +3% | +$8.86K | 0.03% | 395 |
|
|
2021
Q4 | $248K | Hold |
3,300
| – | – | 0.02% | 410 |
|
|
2021
Q3 | $383K | Buy |
3,300
+325
| +11% | +$37.7K | 0.04% | 305 |
|
|
2021
Q2 | $393K | Hold |
2,975
| – | – | 0.06% | 269 |
|
|
2021
Q1 | $393K | Sell |
2,975
-625
| -17% | -$82.6K | 0.07% | 220 |
|
|
2020
Q4 | $623K | Buy |
3,600
+175
| +5% | +$30.3K | 0.12% | 165 |
|
|
2020
Q3 | $381K | Sell |
3,425
-525
| -13% | -$58.4K | 0.09% | 192 |
|
|
2020
Q2 | $234K | Sell |
3,950
-2,400
| -38% | -$142K | 0.07% | 223 |
|
|
2020
Q1 | $428K | Hold |
6,350
| – | – | 0.15% | 140 |
|
|
2019
Q4 | $535K | Buy |
+6,350
| New | +$535K | 0.15% | 141 |
|